Michael Schwameis - Concepedia

Author

Michael Schwameis

Also Known As

Andrew Blann, B Steinlechner, Janet T Scott, Justin Schaffer, M Schwameis, M. Schwameis, MICHAEL SCHWAMEIS, Michael Schwameis, Schwameis M, Stephan Schroll

144

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Monash University Comprehensive Cancer Center Vienna Heidelberg University

About

Michael Schwameis is an author at Medical University of Vienna specializing in medicine, emergency medicine, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	531
2	Engineering	1	1	65
3	Health Sciences	1	1	16
4	Public Health	1	1	17
5	Allergy	1	1	30

Michael Schwameis

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial Katrin Ramsauer, Michael Schwameis, Christa Firbas, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyVaccine DevelopmentFirst-in-man Trial	2015	227
A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a<i>Pseudomonas aeruginosa</i>hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers Kerstin Westritschnig, Romana Hochreiter, Gerhard Wallner, Human Vaccines & Immunotherapeutics	2013	83
Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers Eva‐Luise Hobl, Birgit Reiter, Christian Schoergenhofer, European Journal of Clinical Investigation	2015	73
Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers Eva‐Luise Hobl, Birgit Reiter, Christian Schoergenhofer, Clinical Research in Cardiology	2015	71
D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study Michael Schwameis, M. Steiner, Christian Schoergenhofer, European Journal of Internal Medicine	2015	71
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration Alexander Spiel, Johann Bartko, Michael Schwameis, Thrombosis and Haemostasis EngineeringImmunologyBlood CellPlatelet PathobiologyBiomedical Engineering	2011	65
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting <i>Staphylococcus aureus</i> Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers Zoltán Magyarics, Fraser Leslie, Johann Bartko, Antimicrobial Agents and Chemotherapy	2019	58
A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway Johann Bartko, Christian Schoergenhofer, Michael Schwameis, Clinical Pharmacology & Therapeutics	2018	57
Mortality in patients resuscitated from out-of-hospital cardiac arrest based on automated blood cell count and neutrophil lymphocyte ratio at admission Christoph Weiser, Michael Schwameis, Fritz Sterz, Resuscitation Cardiopulmonary ResuscitationHospital MedicineMedicineNeutrophil Lymphocyte RatioHematology	2017	51
Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation Michael Schwameis, Andreas Schober, Christian Schörgenhofer, Critical Care Medicine	2015	48

Page 1